N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations

Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite

(2022) Joerg Schlingemann et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study

(2021) Kausik K. Nanda et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Nitrosamine Reactivity: A Survey of Reactions and Purge Processes

(2021) Christopher J. Borths et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Potential for the Formation of N-Nitrosamines During the Manufacture of Active Pharmaceutical Ingredients: An Assessment of the Risk Posed by Trace Nitrite in Water

(2020) Ian W. Ashworth et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products

(2019) David J. Snodin et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Degradation Rate Observations as a Function of Drug Load in Solid-State Drug Products

(2018) Steven W. Baertschi et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient Incompatibility

(2011) Yongmei Wu et al.   AAPS PHARMSCITECH

Impact of Counterion on the Chemical Stability of Crystalline Salts of Procaine

(2009) Peter Guerrieri et al.   JOURNAL OF PHARMACEUTICAL SCIENCES